Common antibiotic found 99.9% effective against typhoid

Updated on: July 09,2025 0

Common antibiotic found 99.9% effective against typhoid

Updated on:July 09,2025 0

Genetic subtypes in T-follicular helper lymphoma linked to patient outcomes

Updated on: July 13,2025 0

Genetic subtypes in T-follicular helper lymphoma linked to patient outcomes

Updated on:July 13,2025 0

FDA approves polypill Widaplik for hypertension

Updated on: July 10,2025 0

FDA approves polypill Widaplik for hypertension

Updated on:July 10,2025 0

Researchers challenge FDA warning on common epilepsy drug

Updated on: July 09,2025 0

Researchers challenge FDA warning on common epilepsy drug

Updated on:July 09,2025 0

More young women are getting breast cancer—why?

Updated on: July 11,2025 0

More young women are getting breast cancer—why?

Updated on:July 11,2025 0

Researchers uncover a potential new therapeutic target for a hard-to-treat form of leukemia

Updated on: July 11,2025 0

Researchers uncover a potential new therapeutic target for a hard-to-treat form of leukemia

Updated on:July 11,2025 0

Germany's BioNTech to buy CureVac to boost cancer research

Updated on: July 08,2025 0

Germany's BioNTech to buy CureVac to boost cancer research

Updated on:July 08,2025 0

Enzyme inhibitor strategy converts neuroblastoma cells into healthy neurons in mice

Updated on: July 10,2025 0

Enzyme inhibitor strategy converts neuroblastoma cells into healthy neurons in mice

Updated on:July 10,2025 0

Protein 'referee' could hold key to stopping some breast cancers from spreading

Updated on: July 12,2025 0

Protein 'referee' could hold key to stopping some breast cancers from spreading

Updated on:July 12,2025 0

Study shows the glucocorticoid receptor is a double-edged sword in prostate cancer

Updated on: July 14,2025 0

Study shows the glucocorticoid receptor is a double-edged sword in prostate cancer

Updated on:July 14,2025 0